Learn more about whether Biogen Inc. or Natera, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
7h
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback